Zolpimist - Drug Details
๐Ÿ“Š Estimates Zolpimist Dialyzability By Different_Modalities

Zolpimist

Complete Drug Information

Drug Name
Zolpimist
Trade Names
Ambien
Pregnancy Category
AU: B3
Bioavailability
70% (by mouth)
Routes of Administration
Oral, sublingual, oromucosal (spray), rectal
Protein Binding
92%%
Metabolism
Liver through CYP3A4 (~60%), CYP2C9 (~20%), and CYP1A2 (~14%)
Elimination
2โ€“3 hours
Excretion
Kidney (56%)fecal (34%)
Formula
C19H21N3O
Molar Mass
307.397
Onset of Action
15 minutes
Duration of Action
3 hours
Melting Point
193โ€“197ย ยฐC
Drug Class
Nonbenzodiazepine, sedative-hypnotic
Volume of Distribution
C19H21N3O

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.